Hepatic Venoocclusive Disease with Immunodeficiency Approved Drugs
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hepatic Venoocclusive Disease with Immunodeficiency.
Found 1 Approved Drug for Hepatic Venoocclusive Disease with Immunodeficiency
Defitelio
Generic Name
Defibrotide
Defitelio
Generic Name
Defibrotide
Form: Injection
Method of administration: Intravenous
FDA approval date: March 30, 2016
DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT). DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT). ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances